Estimating medical expenditure associated with osteoporotic hip fracture in elderly Korean women based on the national health insurance claims database 2002-2004

Hye Young Kang, Sung Eun Park, Dae Ryong Kang, Ji Yoon Kim, Young Hwa Jang, Won Jung Choi, Seong Hwan Moon, Kyu Hyun Yang, Jin Young Park, Soon Yong Kwon

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objectives: To estimate the medical expenditure associated with osteoporotic hip fracture in elderly Korean women from insurer's perspective. Methods: All claim records of women aged ≥50 years and diagnosed with hip fracture from 2002 to 2004 were obtained from the Korean National Health Insurance. The first 6 months were considered a "window period" during which patients with fractures were defined as incident cases if their initial records of visit or admission were observed after June 30, 2002. We included only those with claim records showing diagnosis of osteoporosis or prescription for antiosteoporosis drugs. For each patient, we calculated the cumulative claims amount related to the initial and follow-up treatment for 2 years after fracture. Results: A total of 22,247 patients were identified during 2.5 years. During the first year of fracture, an average of 3.28 visits and 0.97 admissions were recorded; during the second year, 0.35 visits and 0.02 admissions were recorded. The 2-year cost per patient was KRW3,175,467, 97.4% of which was incurred during first year. Conclusion: Exploring the economic burden of osteoporotic hip fracture in the elderly women is expected to motivate policymakers and clinicians to adopt effective treatment options for the disease prevention and expenditure control.

Original languageEnglish
Pages (from-to)S93-S96
JournalValue in Health
Volume12
Issue numberSUPPL. 3
DOIs
Publication statusPublished - 2009 Jan 1

Fingerprint

Osteoporotic Fractures
Hip Fractures
National Health Programs
Health Expenditures
Databases
Insurance Carriers
Prescription Drugs
Osteoporosis
Economics
Costs and Cost Analysis
Therapeutics

All Science Journal Classification (ASJC) codes

  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

Kang, Hye Young ; Park, Sung Eun ; Kang, Dae Ryong ; Kim, Ji Yoon ; Jang, Young Hwa ; Choi, Won Jung ; Moon, Seong Hwan ; Yang, Kyu Hyun ; Park, Jin Young ; Kwon, Soon Yong. / Estimating medical expenditure associated with osteoporotic hip fracture in elderly Korean women based on the national health insurance claims database 2002-2004. In: Value in Health. 2009 ; Vol. 12, No. SUPPL. 3. pp. S93-S96.
@article{cd7911954a5b4e6293ba6e6cb362f096,
title = "Estimating medical expenditure associated with osteoporotic hip fracture in elderly Korean women based on the national health insurance claims database 2002-2004",
abstract = "Objectives: To estimate the medical expenditure associated with osteoporotic hip fracture in elderly Korean women from insurer's perspective. Methods: All claim records of women aged ≥50 years and diagnosed with hip fracture from 2002 to 2004 were obtained from the Korean National Health Insurance. The first 6 months were considered a {"}window period{"} during which patients with fractures were defined as incident cases if their initial records of visit or admission were observed after June 30, 2002. We included only those with claim records showing diagnosis of osteoporosis or prescription for antiosteoporosis drugs. For each patient, we calculated the cumulative claims amount related to the initial and follow-up treatment for 2 years after fracture. Results: A total of 22,247 patients were identified during 2.5 years. During the first year of fracture, an average of 3.28 visits and 0.97 admissions were recorded; during the second year, 0.35 visits and 0.02 admissions were recorded. The 2-year cost per patient was KRW3,175,467, 97.4{\%} of which was incurred during first year. Conclusion: Exploring the economic burden of osteoporotic hip fracture in the elderly women is expected to motivate policymakers and clinicians to adopt effective treatment options for the disease prevention and expenditure control.",
author = "Kang, {Hye Young} and Park, {Sung Eun} and Kang, {Dae Ryong} and Kim, {Ji Yoon} and Jang, {Young Hwa} and Choi, {Won Jung} and Moon, {Seong Hwan} and Yang, {Kyu Hyun} and Park, {Jin Young} and Kwon, {Soon Yong}",
year = "2009",
month = "1",
day = "1",
doi = "10.1111/j.1524-4733.2009.00637.x",
language = "English",
volume = "12",
pages = "S93--S96",
journal = "Value in Health",
issn = "1098-3015",
publisher = "Elsevier Limited",
number = "SUPPL. 3",

}

Estimating medical expenditure associated with osteoporotic hip fracture in elderly Korean women based on the national health insurance claims database 2002-2004. / Kang, Hye Young; Park, Sung Eun; Kang, Dae Ryong; Kim, Ji Yoon; Jang, Young Hwa; Choi, Won Jung; Moon, Seong Hwan; Yang, Kyu Hyun; Park, Jin Young; Kwon, Soon Yong.

In: Value in Health, Vol. 12, No. SUPPL. 3, 01.01.2009, p. S93-S96.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Estimating medical expenditure associated with osteoporotic hip fracture in elderly Korean women based on the national health insurance claims database 2002-2004

AU - Kang, Hye Young

AU - Park, Sung Eun

AU - Kang, Dae Ryong

AU - Kim, Ji Yoon

AU - Jang, Young Hwa

AU - Choi, Won Jung

AU - Moon, Seong Hwan

AU - Yang, Kyu Hyun

AU - Park, Jin Young

AU - Kwon, Soon Yong

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Objectives: To estimate the medical expenditure associated with osteoporotic hip fracture in elderly Korean women from insurer's perspective. Methods: All claim records of women aged ≥50 years and diagnosed with hip fracture from 2002 to 2004 were obtained from the Korean National Health Insurance. The first 6 months were considered a "window period" during which patients with fractures were defined as incident cases if their initial records of visit or admission were observed after June 30, 2002. We included only those with claim records showing diagnosis of osteoporosis or prescription for antiosteoporosis drugs. For each patient, we calculated the cumulative claims amount related to the initial and follow-up treatment for 2 years after fracture. Results: A total of 22,247 patients were identified during 2.5 years. During the first year of fracture, an average of 3.28 visits and 0.97 admissions were recorded; during the second year, 0.35 visits and 0.02 admissions were recorded. The 2-year cost per patient was KRW3,175,467, 97.4% of which was incurred during first year. Conclusion: Exploring the economic burden of osteoporotic hip fracture in the elderly women is expected to motivate policymakers and clinicians to adopt effective treatment options for the disease prevention and expenditure control.

AB - Objectives: To estimate the medical expenditure associated with osteoporotic hip fracture in elderly Korean women from insurer's perspective. Methods: All claim records of women aged ≥50 years and diagnosed with hip fracture from 2002 to 2004 were obtained from the Korean National Health Insurance. The first 6 months were considered a "window period" during which patients with fractures were defined as incident cases if their initial records of visit or admission were observed after June 30, 2002. We included only those with claim records showing diagnosis of osteoporosis or prescription for antiosteoporosis drugs. For each patient, we calculated the cumulative claims amount related to the initial and follow-up treatment for 2 years after fracture. Results: A total of 22,247 patients were identified during 2.5 years. During the first year of fracture, an average of 3.28 visits and 0.97 admissions were recorded; during the second year, 0.35 visits and 0.02 admissions were recorded. The 2-year cost per patient was KRW3,175,467, 97.4% of which was incurred during first year. Conclusion: Exploring the economic burden of osteoporotic hip fracture in the elderly women is expected to motivate policymakers and clinicians to adopt effective treatment options for the disease prevention and expenditure control.

UR - http://www.scopus.com/inward/record.url?scp=72149117378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72149117378&partnerID=8YFLogxK

U2 - 10.1111/j.1524-4733.2009.00637.x

DO - 10.1111/j.1524-4733.2009.00637.x

M3 - Article

C2 - 20586992

AN - SCOPUS:72149117378

VL - 12

SP - S93-S96

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - SUPPL. 3

ER -